Skip to content
SlushFund

Agencies · awarding agency 075 · HHS

Department of Health and Human Services

Share of this agency’s prime contract dollars that it coded “not competed”, by fiscal year, from USAspending’s agency totals.

FY2024
9.2%

of contract dollars were not competed: $2.8B of $29.9B

USAspendingas of Oct 3
FY2025
11.5%

of contract dollars were not competed: $2.5B of $21.3B

USAspendingas of Oct 3
FY2026
11.6%

of contract dollars were not competed: $2.9B of $24.9B

USAspendingas of Oct 3
Source: USAspending.govCoverage: Agency contract totals FY2024–FY2026 · Contract awards FY2024–FY2026Updated: Methodology →

Contract dollars by fiscal year

All prime contract obligations of the agency, split by the agency's competition code. Every figure is from USAspending's agency totals.

Contract obligations, non-competed and competed, by fiscal year
Fiscal yearAll contract obligationsNot competedCompetedShare not competed
FY2024Oct 1 – Sep 30, 2024$29.9B$2.8B$27.1B9.2%
FY2025Oct 1 – Sep 30, 2025$21.3B$2.5B$18.8B11.5%
FY2026Oct 1 – Sep 30, 2026$24.9B$2.9B$22.0B11.6%

Source: USAspending.gov agency totals, prime contract types A–D, by contract-action date; fetched Oct 3, 2026. “Not competed” = extent-competed code not available for competition, not competed, not competed under simplified acquisition, or non-competitive delivery order. Orders placed under a competed contract keep its code, so they count as competed.

Largest non-competed awards in our records

A look at the biggest individual awards behind the share. These rows do not add up to the totals above.

Largest non-competed awards from Department of Health and Human Services, FY2024–26 (obligated to date)
Source
7571MN26C00029LEGAL SERVICES BRIDGE 2.0OUR RESCUEAug 7, 2026FY2026Not competedUrgency (FAR 6.302-2)$158,124,790USAspending
75A50124C00057ERVEBO PROCUREMENTMERCK SHARP & DOHME LLCSep 27, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$156,033,983USAspending
75A50324C00006ANTHIM (OBILTOXAXIMAB)ELUSYS THERAPEUTICS INCApr 30, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$124,523,123USAspending
75N99024F00038Order under IDV 47PA0420D0064C107469 ELECTRICAL SUBSTATION UPGRADE PHASE 1APOTOMAC ELECTRIC POWER COSep 26, 2024FY2024Not available for competitionUtilities (FAR 6.302-1(b)(3))$122,189,393USAspending
75N90025C00008PHARMACEUTICALS AND RELATED SUPPLIES FOR NIH CLINICAL CENTER, PHARMACY DEPT. UNITED STATES DEPARTMENT OF DEFENSE:1133869 [25-001813]DLA TROOP SUPPORTFeb 6, 2025FY2025Not competedOnly one source-other (FAR 6.302-1 other)$93,536,123USAspending
75N90024C00007PHARMACEUTICALS AND RELATED SUPPLIES FOR THE NIH CLINICAL CENTER (CC), PHARMACY DEPARTMENT.DLA TROOP SUPPORTNov 14, 2023FY2024Not competedOnly one source-other (FAR 6.302-1 other)$82,620,000USAspending
75N98026C00026PHARMACEUTICALS AND RELATED SUPPLIES UNITED STATES DEPARTMENT OF DEFENSE:1133869 [26-003472]DLA TROOP SUPPORTApr 9, 2026FY2026Not competedOnly one source-other (FAR 6.302-1 other)$77,389,000USAspending
75D30124C19450DOSE RECONSTRUCTIONOAK RIDGE ASSOCIATED UNIVERSITIES, INCORPORATEDAug 9, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$57,750,000USAspending
75A50125C00002MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINESANOFI VACCINES US INC.Jan 31, 2025FY2025Not competedOnly one source-other (FAR 6.302-1 other)$53,212,199USAspending
75D30125C20468ATL FT COLLINS GUARDS BRIDGECHENEGA GLOBAL PROTECTION, LLCSep 4, 2025FY2025Not competedOnly one source-other (FAR 6.302-1 other)$49,658,504USAspending
75A50325C00019RELENZA (ZANAMIVIR) ROTADISK, 5MGGLAXOSMITHKLINE, LLCSep 26, 2025FY2025Not competedOnly one source-other (FAR 6.302-1 other)$45,499,950USAspending
75FCMC24F0196Order under IDV 75FCMC23D0004POLICY AND OPERATIONAL SERVICES IN SUPPORT OF THE CONSUMER SUPPORT GROUP (CSG) FOR THE CENTER FOR CONSUMER INFORMATION AND INSURANCE OVERSIGHT (CCIIO)THE MITRE CORPORATIONSep 23, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$45,440,097USAspending
75D30126C21564EO 14398 - CDC EMERGENCY MASS NOTIFICATION SYSTEM (EMNS)CHENEGA ENTERPRISE SYSTEMS & SOLUTIONS, LLCSep 28, 2026FY2026Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$37,385,495USAspending
75R60225C00001PRB184 C 5299 COVID-19 UNINSURED AND PROVIDER RELIEF FUND CLOSE-OUT SERVICESOPTUMSERVE TECHNOLOGY SERVICES, INC.Oct 11, 2024FY2025Not competedOnly one source-other (FAR 6.302-1 other)$35,520,831USAspending
75FCMC24F0200Order under IDV 75FCMC23D0004STRATEGIC SERVICES IN SUPPORT OF FACILITATING LEADERSHIP IN ADVANCED MEASUREMENT EXCELLENCE (FLAME)THE MITRE CORPORATIONSep 16, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$35,210,195USAspending
75ACF124C00023CASE COORDINATION BRIDGEGENERAL DYNAMICS INFORMATION TECHNOLOGY, INC.Sep 30, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$35,175,033USAspending
75FCMC24F0100Order under IDV 75FCMC23D0004TITLE IS SOLUTIONS TO SUPPORT INNOVATION IN PURSUIT OF AFFORDABLE AND BETTER HEALTH CARETHE MITRE CORPORATIONJun 26, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$33,645,144USAspending
75A50325C00020RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)RAFA LABORATORIES LTDSep 30, 2025FY2025Not competedOnly one source-other (FAR 6.302-1 other)$33,392,937USAspending
75F40126C00029SENTINEL 2.0 BRIDGE CONTRACTHARVARD PILGRIM HEALTH CARE, INC.Mar 26, 2026FY2026Not competedOnly one source-other (FAR 6.302-1 other)$32,918,651USAspending
75FCMC25FJ092Order under IDV 75FCMC23D0004THE PURPOSE OF THIS REWARD IS TO REPLACE THE ORIGINAL ADVANCING THE MEDICAID IT AMIT AWARD 75FCMC18D0047/ 75FCMC25FJ068 DUE TO AN ADMINISTRATIVE ERROR WHICH OCCURRED AT THE TIME OF AWARD. NONE OF THE TERMS AND CONDITIONS HAVE CHANGES AND ALL ATTACHMETHE MITRE CORPORATIONJul 30, 2025FY2025Not competedMobilization, essential r&d (FAR 6.302-3)$26,686,962USAspending
75A50424C00006OVER THE COUNTER (OTC) COVID-19 TESTS - GAO CORRECTIVE ACTIONATLANTIC TRADING LLCSep 5, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$26,510,400USAspending
75D30124C19403NATIONAL PROGRAM OF CANCER REGISTRIES CANCER SURVEILLANCE INFORMATICS SYSTEMGC&E FEDERAL, LLCJul 17, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$26,321,728USAspending
75P00125C00034HHS PROCESSES IMPROVEMENT & ATO TRANSFORMATIONSKYLIGHT INC.Sep 30, 2025FY2025Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$25,242,264USAspending
75D30126C20921DOSE RECONSTRUCTION AND RELATED ACTIVITIES TO SUPPORT NIOSH'S RESPONSIBILITIES UNDER THE EEOICPAOAK RIDGE ASSOCIATED UNIVERSITIES, INCORPORATEDApr 17, 2026FY2026Not competedOnly one source-other (FAR 6.302-1 other)$24,823,495USAspending
75H70124C00052WESTERN OREGON SERVICE UNIT (WOSU) SCHOOL BASED HEALTH CENTER (SBHC) DESIGN-BUILDTSS-JCC LLCSep 27, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$22,640,641USAspending

Largest non-competed awards from Department of Health and Human Services, FY2024–26 (obligated to date)

  • 7571MN26C00029LEGAL SERVICES BRIDGE 2.0
    Signed
    Aug 7, 2026FY2026
    Competition
    Not competedUrgency (FAR 6.302-2)
    Obligated to date
    $158,124,790
  • 75A50124C00057ERVEBO PROCUREMENT
    Signed
    Sep 27, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $156,033,983
  • 75A50324C00006ANTHIM (OBILTOXAXIMAB)
    Signed
    Apr 30, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $124,523,123
  • 75N99024F00038Order under IDV 47PA0420D0064C107469 ELECTRICAL SUBSTATION UPGRADE PHASE 1A
    Signed
    Sep 26, 2024FY2024
    Competition
    Not available for competitionUtilities (FAR 6.302-1(b)(3))
    Obligated to date
    $122,189,393
  • 75N90025C00008PHARMACEUTICALS AND RELATED SUPPLIES FOR NIH CLINICAL CENTER, PHARMACY DEPT. UNITED STATES DEPARTMENT OF DEFENSE:1133869 [25-001813]
    Signed
    Feb 6, 2025FY2025
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $93,536,123
  • 75N90024C00007PHARMACEUTICALS AND RELATED SUPPLIES FOR THE NIH CLINICAL CENTER (CC), PHARMACY DEPARTMENT.
    Signed
    Nov 14, 2023FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $82,620,000
  • 75N98026C00026PHARMACEUTICALS AND RELATED SUPPLIES UNITED STATES DEPARTMENT OF DEFENSE:1133869 [26-003472]
    Signed
    Apr 9, 2026FY2026
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $77,389,000
  • 75D30124C19450DOSE RECONSTRUCTION
    Signed
    Aug 9, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $57,750,000
  • 75A50125C00002MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE
    Signed
    Jan 31, 2025FY2025
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $53,212,199
  • 75D30125C20468ATL FT COLLINS GUARDS BRIDGE
    Signed
    Sep 4, 2025FY2025
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $49,658,504
  • 75A50325C00019RELENZA (ZANAMIVIR) ROTADISK, 5MG
    Signed
    Sep 26, 2025FY2025
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $45,499,950
  • 75FCMC24F0196Order under IDV 75FCMC23D0004POLICY AND OPERATIONAL SERVICES IN SUPPORT OF THE CONSUMER SUPPORT GROUP (CSG) FOR THE CENTER FOR CONSUMER INFORMATION AND INSURANCE OVERSIGHT (CCIIO)
    Signed
    Sep 23, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $45,440,097
  • 75D30126C21564EO 14398 - CDC EMERGENCY MASS NOTIFICATION SYSTEM (EMNS)
    Signed
    Sep 28, 2026FY2026
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $37,385,495
  • 75R60225C00001PRB184 C 5299 COVID-19 UNINSURED AND PROVIDER RELIEF FUND CLOSE-OUT SERVICES
    Signed
    Oct 11, 2024FY2025
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $35,520,831
  • 75FCMC24F0200Order under IDV 75FCMC23D0004STRATEGIC SERVICES IN SUPPORT OF FACILITATING LEADERSHIP IN ADVANCED MEASUREMENT EXCELLENCE (FLAME)
    Signed
    Sep 16, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $35,210,195
  • 75ACF124C00023CASE COORDINATION BRIDGE
    Signed
    Sep 30, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $35,175,033
  • 75FCMC24F0100Order under IDV 75FCMC23D0004TITLE IS SOLUTIONS TO SUPPORT INNOVATION IN PURSUIT OF AFFORDABLE AND BETTER HEALTH CARE
    Signed
    Jun 26, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $33,645,144
  • 75A50325C00020RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)
    Signed
    Sep 30, 2025FY2025
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $33,392,937
  • 75F40126C00029SENTINEL 2.0 BRIDGE CONTRACT
    Signed
    Mar 26, 2026FY2026
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $32,918,651
  • 75FCMC25FJ092Order under IDV 75FCMC23D0004THE PURPOSE OF THIS REWARD IS TO REPLACE THE ORIGINAL ADVANCING THE MEDICAID IT AMIT AWARD 75FCMC18D0047/ 75FCMC25FJ068 DUE TO AN ADMINISTRATIVE ERROR WHICH OCCURRED AT THE TIME OF AWARD. NONE OF THE TERMS AND CONDITIONS HAVE CHANGES AND ALL ATTACHME
    Signed
    Jul 30, 2025FY2025
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $26,686,962
  • 75A50424C00006OVER THE COUNTER (OTC) COVID-19 TESTS - GAO CORRECTIVE ACTION
    Signed
    Sep 5, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $26,510,400
  • 75D30124C19403NATIONAL PROGRAM OF CANCER REGISTRIES CANCER SURVEILLANCE INFORMATICS SYSTEM
    Signed
    Jul 17, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $26,321,728
  • 75P00125C00034HHS PROCESSES IMPROVEMENT & ATO TRANSFORMATION
    Signed
    Sep 30, 2025FY2025
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $25,242,264
  • 75D30126C20921DOSE RECONSTRUCTION AND RELATED ACTIVITIES TO SUPPORT NIOSH'S RESPONSIBILITIES UNDER THE EEOICPA
    Signed
    Apr 17, 2026FY2026
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $24,823,495
  • 75H70124C00052WESTERN OREGON SERVICE UNIT (WOSU) SCHOOL BASED HEALTH CENTER (SBHC) DESIGN-BUILD
    Signed
    Sep 27, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $22,640,641
The 25 largest non-competed awards of $1M+ signed in FY2024–26 (rule r5-v1). “Obligated to date” is the total committed on the award so far, including later modifications, not spending in a fiscal year. Source: USAspending.gov award records.